PD-L1 expression on tumor-infiltrating immune cells (macrophages and dendritic cells), but not tumor cells, correlated with responses,41 which may explain the lack of efficacy of checkpoint blockade in a subset of PD-L1-high patients. This evidence concerns the gene CD274 and neoplasm.